2395 related articles for article (PubMed ID: 19686699)
41. Toll-like receptors' two-edged sword: when immunity meets apoptosis.
Salaun B; Romero P; Lebecque S
Eur J Immunol; 2007 Dec; 37(12):3311-8. PubMed ID: 18034428
[TBL] [Abstract][Full Text] [Related]
42. TLRs and chronic inflammation.
Ospelt C; Gay S
Int J Biochem Cell Biol; 2010 Apr; 42(4):495-505. PubMed ID: 19840864
[TBL] [Abstract][Full Text] [Related]
43. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
Fukata M; Vamadevan AS; Abreu MT
Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
[TBL] [Abstract][Full Text] [Related]
44. Toll-like receptors and their role in host resistance to Toxoplasma gondii.
Yarovinsky F
Immunol Lett; 2008 Aug; 119(1-2):17-21. PubMed ID: 18617274
[TBL] [Abstract][Full Text] [Related]
45. Innate immune signals in atherosclerosis.
Lundberg AM; Hansson GK
Clin Immunol; 2010 Jan; 134(1):5-24. PubMed ID: 19740706
[TBL] [Abstract][Full Text] [Related]
46. Intracellular toll-like receptors.
Blasius AL; Beutler B
Immunity; 2010 Mar; 32(3):305-15. PubMed ID: 20346772
[TBL] [Abstract][Full Text] [Related]
47. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism.
Gazzinelli RT; Denkers EY
Nat Rev Immunol; 2006 Dec; 6(12):895-906. PubMed ID: 17110955
[TBL] [Abstract][Full Text] [Related]
48. Toll-like receptors and control of mycobacterial infection in mice.
Ryffel B; Jacobs M; Parida S; Botha T; Togbe D; Quesniaux V
Novartis Found Symp; 2006; 279():127-39; discussion 139-41, 216-9. PubMed ID: 17278391
[TBL] [Abstract][Full Text] [Related]
49. Toll-like receptors in inflammation of the central nervous system.
Kong Y; Le Y
Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
[TBL] [Abstract][Full Text] [Related]
50. Recognition of bacterial infection by innate immune sensors.
Kumar S; Ingle H; Prasad DV; Kumar H
Crit Rev Microbiol; 2013 Aug; 39(3):229-46. PubMed ID: 22866947
[TBL] [Abstract][Full Text] [Related]
51. Role of Toll-like receptors in liver health and disease.
Broering R; Lu M; Schlaak JF
Clin Sci (Lond); 2011 Nov; 121(10):415-26. PubMed ID: 21797822
[TBL] [Abstract][Full Text] [Related]
52. Innate immunity: cells, receptors, and signaling pathways.
Błach-Olszewska Z
Arch Immunol Ther Exp (Warsz); 2005; 53(3):245-53. PubMed ID: 15995585
[TBL] [Abstract][Full Text] [Related]
53. Still waiting for the toll?
Cooper EL; Kvell K; Engelmann P; Nemeth P
Immunol Lett; 2006 Apr; 104(1-2):18-28. PubMed ID: 16368151
[TBL] [Abstract][Full Text] [Related]
54. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond.
Lahiri A; Das P; Chakravortty D
Vaccine; 2008 Dec; 26(52):6777-83. PubMed ID: 18835576
[TBL] [Abstract][Full Text] [Related]
55. What is the role of Toll-like receptors in bacterial infections?
Gerold G; Zychlinsky A; de Diego JL
Semin Immunol; 2007 Feb; 19(1):41-7. PubMed ID: 17280841
[TBL] [Abstract][Full Text] [Related]
56. Pathogen recognition receptors: ligands and signaling pathways by Toll-like receptors.
Sasai M; Yamamoto M
Int Rev Immunol; 2013 Apr; 32(2):116-33. PubMed ID: 23570313
[TBL] [Abstract][Full Text] [Related]
57. Fungal attacks on mammalian hosts: pathogen elimination requires sensing and tasting.
Bourgeois C; Majer O; Frohner IE; Tierney L; Kuchler K
Curr Opin Microbiol; 2010 Aug; 13(4):401-8. PubMed ID: 20538507
[TBL] [Abstract][Full Text] [Related]
58. Differences in innate immune responses upon stimulation with gram-positive and gram-negative bacteria.
Tietze K; Dalpke A; Morath S; Mutters R; Heeg K; Nonnenmacher C
J Periodontal Res; 2006 Oct; 41(5):447-54. PubMed ID: 16953821
[TBL] [Abstract][Full Text] [Related]
59. Pathogen recognition and innate immunity.
Akira S; Uematsu S; Takeuchi O
Cell; 2006 Feb; 124(4):783-801. PubMed ID: 16497588
[TBL] [Abstract][Full Text] [Related]
60. Bacterial modulation of mucosal innate immunity.
Kelly D; Conway S
Mol Immunol; 2005 May; 42(8):895-901. PubMed ID: 15829279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
